New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab

Nagashree Seetharamu, Isabel R Preeshagul, Kevin M Sullivan Monter Cancer Center, Hofstra-Northwell Health School of Medicine, Lake Success, NY, USA Abstract: The era of immunotherapy has changed the face of how we approach treatment for many oncologic and hematologic malignancies....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Seetharamu N, Preeshagul IR, Sullivan KM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/8a0a5dfc63c14e2b808511bcd61aa5dd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!